Navigation Links
Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation
Date:7/31/2008

Murray Grossan, MD (creator of the Hydro-Pulse sinus irrigation device) describes his successful treatment protocol for applying antibiotics, anti-fungals and anti-inflammatories directly into the sinus cavities using a pulsating irrigation device. This treatment has been extremely helpful for his patients who experience symptoms of sinus infections, snoring and sleep apnea. http://abclocal.go.com/kabc/story?section=news/health&id=6231390

Los Angeles, CA (PRWEB) August 1, 2008 -- Dr. Murray Grossan releases new information today regarding his new treatment protocol for sinus infections. Tower ENT gets many requests from doctors regarding his method of administering medications via pulsatile irrigation with the Hydro-Pulse. Dr. Murray Grossan shares his insight into this treatment protocol to provide maximum success for his patients. His method is based on the Bernoulli principle: as a liquid stream passes an opening, it creates a vacuum, which displaces the contents. Because his device uses gentle pulsatile irrigation, this effect is amplified by a steady pumping action.

The liquid reservoir of the Hydro-Pulse™ is clearly marked as to volume of liquid. To achieve maximum effect, the patient administers their medications as follows:

1. The patient fills the reservoir with 500 cc of sterile water and adds one packet (1 tsp) of Breathe-EaseXL™. (This makes a 1% modified Ringer's saline solution)
2. The patient then attaches the nasal tip to the handle and irrigates approximately 150 cc through each nostril
3. After completing the 300 cc, they stop and gently clear their nose
4. The patient then adds their ampoule of medication to the remaining 200 cc of saline and irrigates again approximately 100 cc into each nostril
5. When finished, the patient will stop and sit quietly at the sink for 10 minutes with no blowing
6. The patient is instructed to not blow their nose for the next hour

Which medications should be used? Dr. Grossan initially began with Tobramycin added to 200 cc of saline. Today he often cultures the infection and adds the appropriate medications accordingly. For fungal infections, he use antifungals (such as Amphotericin B or Itraconazole). For inflammation, he adds an anti-inflammatory (such as Mometasone or Betamethasone). "Of course, patients really appreciate this simple topical method vs. taking systemic oral antibiotics," states Dr. Grossan. "One important factor here is that the medications come in a sealed vial -- the patient just pops the top and squeezes out its contents. This is vital for many medications that are unstable and removes the need for preservatives. Note that we add Amphotericin B to saline. This is fine as long as the mix is used right away before it precipitates."

More information regarding this unique treatment protocol and a complete list of medications commonly used at Tower ENT, may be found at http://www.aslrx.com/when_should_I.shtml [ASL Pharmacy]. These medications require a prescription. Information on how to acquire these medications and device may be obtained through ASL Pharmacy at 866-552-7579.

# # #

Read the full story at http://www.prweb.com/releases/Hydro/Pulse/prweb1149014.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Boston Scientifics SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
2. Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers
3. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
4. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
5. Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference
6. Cynthia Haines, M.D., Named Managing Editor of Physicians Briefing News Wire
7. Young Physicians Demanding Advanced Laparoscopic Energy Instruments
8. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
9. Physicians Practice, Loma Linda Partner to Improve Patient Care in Southern California
10. Physicians Reference Laboratory Announces New Diagnostic for Womens Health
11. Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation 
(Date:5/19/2016)... 19, 2016 Regen ... PINK: RGBPP) announced today initiation of a preclinical ... blood based cancer immunotherapeutic product leveraging its NR2F6 ... described a generation of cord blood derived killer ... silencing.  The product in development will be a ...
(Date:5/18/2016)... Irvine, Calif. (PRWEB) , ... May 18, 2016 , ... ... had awarded the Luis Villalobos Award to Cognition Therapeutics at the annual ACA Summit ... innovative company that is financed by one of ACA’s member angel groups. It is ...
(Date:5/18/2016)... YORK , May 18, 2016 ... but it does not mean that there are no opportunities ... Threshold Pharmaceuticals Inc. (NASDAQ: THLD ), Seattle Genetics ... CHMA ), and Ophthotech Corp. (NASDAQ: OPHT ... trading alerts at: http://www.activewallst.com/ ...
(Date:5/18/2016)... Washington, PA (PRWEB) , ... May 18, 2016 ... ... at least 1,200 hospitalizations are a direct result of asthma complications.* Costing more ... challenge across the country. , “For too many, the suffering ...
Breaking Biology Technology:
(Date:3/31/2016)... RATON, Florida , March 31, 2016 ... LEGX ) ("LegacyXChange" or the "Company") ... for potential users of its soon to be launched ... video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide ... the use of DNA technology to an industry that ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
(Date:3/22/2016)... , March 22, 2016 ... report "Electronic Sensors Market for Consumer Industry by Type ... Others), Application (Communication & IT, Entertainment, Home ... Global Forecast to 2022", published by MarketsandMarkets, ... expected to reach USD 26.76 Billion by ...
Breaking Biology News(10 mins):